RSV vaccine study targets frail elderly
⭐️ VACCINE ⭐️
Recruiting now
This study looks at how well the RSV vaccine Arexvy works in very old and frail adults (80 years and older) compared to younger seniors (60-65 years). RSV can cause serious lung infections in older people. The goal is to see if the vaccine produces a strong immune response in the…
Phase: PHASE3 • Sponsor: Karin Karin Loré • Aim: ⭐️ VACCINE ⭐️
Last updated May 06, 2026 16:04 UTC